Literature DB >> 15708940

Psoriatic arthritis imaging: a review of scoring methods.

D van der Heijde1, J Sharp, S Wassenberg, D D Gladman.   

Abstract

Structural damage assessed on conventional radiographs is an important outcome measure in psoriatic arthritis. This article reviews the available scoring methods. A full description of the methods is given as well as information on various aspects of validity.

Entities:  

Mesh：

Year:  2005        PMID： 15708940      PMCID： PMC1766859          DOI： 10.1136/ard.2004.030809

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  20 in total

1.  How to read radiographs according to the Sharp/van der Heijde method.

Authors:  D van der Heijde
Journal:  J Rheumatol       Date:  2000-01       Impact factor: 4.666

Review 2.  Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review.

Authors:  T Pincus; G Ferraccioli; T Sokka; A Larsen; R Rau; I Kushner; F Wolfe
Journal:  Rheumatology (Oxford)       Date:  2002-12       Impact factor: 7.580

3.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

4.  Radiological assessment in psoriatic arthritis.

Authors:  P Rahman; D D Gladman; R J Cook; Y Zhou; G Young; D Salonen
Journal:  Br J Rheumatol       Date:  1998-07

5.  How to evaluate measuring methods in the case of non-defined external validity.

Authors:  A Rückmann; B Ehle; H J Trampisch
Journal:  J Rheumatol       Date:  1995-10       Impact factor: 4.666

6.  A method to score radiographic change in psoriatic arthritis.

Authors:  S Wassenberg; V Fischer-Kahle; G Herborn; R Rau
Journal:  Z Rheumatol       Date:  2001-06       Impact factor: 1.372

7.  Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis.

Authors:  P Rahman; E Nguyen; C Cheung; C T Schentag; D D Gladman
Journal:  J Rheumatol       Date:  2001-05       Impact factor: 4.666

8.  Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

Authors:  D D Gladman; V T Farewell; K Wong; J Husted
Journal:  Arthritis Rheum       Date:  1998-06

9.  The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis.

Authors:  Paco M J Welsing; Robert B M Landewé; Piet L C M van Riel; Maarten Boers; Anke M van Gestel; Sjef van der Linden; Hilde L Swinkels; Désirée M F M van der Heijde
Journal:  Arthritis Rheum       Date:  2004-07

10.  Does injectable gold retard radiologic evidence of joint damage in psoriatic arthritis?

Authors:  R Mader; D D Gladman; J Long; J Gough; V T Farewell
Journal:  Clin Invest Med       Date:  1995-04       Impact factor: 0.825
View more
  48 in total

Review 1.  Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology.

Authors:  Philip Mease
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 2.  Psoriatic arthritis and imaging.

Authors:  P A Ory; D D Gladman; P J Mease
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 3.  Does current evidence on disease-modifying antirheumatic drugs for psoriatic arthritis reinforce an effect on radiographic progression? Results from a systematic review and meta-analysis.

Authors:  Mariana Garcia-Leal; Mayra A Reyes-Soto; Ivan Hernandez-Galarza; Neri A Alvarez-Villalobos; Dionicio A Galarza-Delgado; Diana E Flores-Alvarado
Journal:  Clin Rheumatol       Date:  2021-02-12       Impact factor: 2.980

4.  Recent advances in imaging in psoriatic arthritis.

Authors:  René Panduro Poggenborg; Lene Terslev; Susanne Juhl Pedersen; Mikkel Ostergaard
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

5.  Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

Authors:  J A Walsh; A B Gottlieb; B Hoepken; T Nurminen; P J Mease
Journal:  Clin Rheumatol       Date:  2018-09-06       Impact factor: 2.980

Review 6.  [Outcome parameters for use in psoriatic arthritis].

Authors:  J Braun; S Wassenberg
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 7.  Imaging in psoriatic arthritis.

Authors:  Allen Anandarajah
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 8.  [Psoriatic arthritis. Treatment outcome parameters].

Authors:  E Märker-Hermann; F Behrens
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

Review 9.  Clinical assessment and outcome research in spondyloarthritis.

Authors:  Robert B M Landewé; Astrid van Tubergen
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

10.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people.

Authors:  Fausto Salaffi; Marina Carotti; Stefania Gasparini; Michele Intorcia; Walter Grassi
Journal:  Health Qual Life Outcomes       Date:  2009-03-18       Impact factor: 3.186
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.